Investing.com - Croda Intl reported on Tuesday fourth quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Croda Intl announced earnings per share of £0.71 on revenue of £717.4M. Analysts polled by Investing.com anticipated EPS of £84.78 on revenue of £651.60M.
Croda Intl shares are down 2% from the beginning of the year, still down 8.19% from its 52 week high of £6,884.00 set on November 10, 2020. They are under-performing the STOXX 600 which is up 3.56% from the start of the year.
Croda Intl follows other major Healthcare sector earnings this month
Croda Intl's report follows an earnings beat by GlaxoSmithKline on February 3, who reported EPS of £0.233 on revenue of £8.74B, compared to forecasts EPS of £0.2322 on revenue of £8.72B.
Dechra Pharma had missed expectations on February 22 with second quarter EPS of £0.21 on revenue of £299.8M, compared to forecast for EPS of £32.57 on revenue of £239.45M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar